Physiology and pharmacology of amyloid precursor protein

Y Cho, HG Bae, E Okun, TV Arumugam… - Pharmacology & …, 2022 - Elsevier
Amyloid precursor protein (APP) is an evolutionarily conserved transmembrane protein and
a well-characterized precursor protein of amyloid-beta (Aβ) peptides, which accumulate in …

Synapses and Alzheimer's disease

M Sheng, BL Sabatini… - Cold Spring Harbor …, 2012 - cshperspectives.cshlp.org
Alzheimer's disease (AD) is a major cause of dementia in the elderly. Pathologically, AD is
characterized by the accumulation of insoluble aggregates of Aβ-peptides that are …

Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of …

MJ Calkins, M Manczak, P Mao… - Human molecular …, 2011 - academic.oup.com
Increasing evidence suggests that the accumulation of amyloid beta (Aβ) in synapses and
synaptic mitochondria causes synaptic mitochondrial failure and synaptic degeneration in …

Synaptic AMPA receptor plasticity and behavior

HW Kessels, R Malinow - Neuron, 2009 - cell.com
The ability to change behavior likely depends on the selective strengthening and weakening
of brain synapses. The cellular models of synaptic plasticity, long-term potentiation (LTP) …

Oxidative and nitrative stress in neurodegeneration

CA Cobb, MP Cole - Neurobiology of disease, 2015 - Elsevier
Aerobes require oxygen for metabolism and normal free radical formation. As a result,
maintaining the redox homeostasis is essential for brain cell survival due to their high …

Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology

TJ Revett, GB Baker, J Jhamandas, S Kar - Journal of Psychiatry and …, 2013 - jpn.ca
Alzheimer disease is the most prevalent form of dementia globally and is characterized
premortem by a gradual memory loss and deterioration of higher cognitive functions and …

A mouse model of amyloid β oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo

T Tomiyama, S Matsuyama, H Iso… - Journal of …, 2010 - Soc Neuroscience
Although amyloid β (Aβ) oligomers are presumed to cause synaptic and cognitive
dysfunction in Alzheimer's disease (AD), their contribution to other pathological features of …

Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo

JR Cirrito, JE Kang, J Lee, FR Stewart, DK Verges… - Neuron, 2008 - cell.com
Aggregation of amyloid-β (Aβ) peptide into soluble and insoluble forms within the brain
extracellular space is central to the pathogenesis of Alzheimer's disease. Full-length amyloid …

[HTML][HTML] Amyloid beta from axons and dendrites reduces local spine number and plasticity

W Wei, LN Nguyen, HW Kessels, H Hagiwara… - Nature …, 2010 - nature.com
Excessive synaptic loss is thought to be one of the earliest events in Alzheimer's disease.
Amyloid beta (Aβ), a peptide secreted in an activity-modulated manner by neurons, has …

Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease

R Chen, J Zhang, Y Wu, D Wang, G Feng, YP Tang… - Cell reports, 2012 - cell.com
Alzheimer's disease (AD) is the most common cause of dementia among older people.
There are no effective medications currently available to prevent and treat AD and halt …